Bambusa Therapeutics, Inc. reports governance changes

Bambusa Therapeutics, Inc. filed an 8-K covering charter, bylaw or fiscal-year changes and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.